SL STRATEGIES, LLC

Lobbying for ARGENTUM MEDICAL DBA BRAVIDA MEDICAL · leading manufacturer of antimicrobial solutions with an emphasis on hospital and surgery

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $40,000.00 income · posted May 4, 2026

Lobbying activity 3

Budget/Appropriations

Fiscal year 2027 appropriations for rad/nuc countermeasures within the HHS Strategic National Stockpile and Department of Defense.

Health Issues

Policies impacting rad/nuc preparedness and response

Defense

Policies impacting prepositioning of rad/nuc countermeasures.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.